Moreover, BML-284 treatment-induced Wnt/β-catenin activation abolished the promoting effects of PRC1 silencing on the protein levels of ATF4, GRP78, and CHOP in two CRC cell lines (Fig. 7C-F). The gene discussed is PRC1; the disease is colorectal carcinoma.